pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Trientine Hydrochloride
drug · small molecule
save

trientine hydrochloride

Phase 2updated 3mo ago
by Innolife Co Ltd🔗 ChEMBL
Phase 2
community read0 votes

🐶 often sniffed alongside

top 2
  • tagAdCom1 co-mentions · 1 sources
  • tag510(k) Clearance1 co-mentions · 1 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 1 investigational indication.

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand
Trientine Hydrochloride
trade names
Cufence, Metalite, Syprine
generic
trientine hydrochloride
indication
Congestive Heart Failure (Heart Failure)
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 7m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?